erstimulation syndrome[J]. Fertil Steril, 2006,85(1):251254.
[2] Babayof R,Margalioth E J,Huleihel M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial[J]. Hum Reprod, 2006,21(5):12601265.
[3] Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS[J]. Hum Reprod, 2003,18(6):11401141.
[4] Kovacs P,Matyas S,Kaali S G. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyperresponders[J]. Fertil Steril, 2006,85(4):913917.
[5] Ohba T,Ujioka T,Ishikawa K, et al. Ovarian hyperstimulation syndromemodel rats; the manifestation and clinical implication[J]. Mol Cell Endocrinol, 2003,202(12):4752.
[6] Manolopoulos K,Lang U,Gips H, et al. Elevated interleukin10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2001,99(2):226231.
[7] Wang T H,Horng S G,Chang C L, et al. Human chorionic gonadotropininduced ovarian hyperstimulation syndrome is associated with upregulation of vascular endothelial growth factor[J]. J Clin Endocrinol Metab, 2002,87(7):33003308.
[8] Albert C,Garrido N,Mercader A, et al. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome[J]. Mol Hum Reprod, 2002,8(5):409418.
[9] Soares S R,Gomez R,Simon C, et al. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome[J]. Hum Reprod Update, 2008,14(4):321333.
[10] GarciaVelasco J A,Quea G,Piro M, et al. Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebocontrolled trial[J]. Fertil Steril, 2009,92(
上一页 [1] [2] [3] [4] [5] [6] 下一页